ZYXI Zynex, Inc.
Healthcare$0.13+140.38%ClosedMarket Cap: $3.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.04
P/S
0.02
EV/EBITDA
-0.93
DCF Value
$-137.39
FCF Yield
-1240.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
71.6%
Operating Margin
-62.8%
Net Margin
-68.4%
ROE
-1807.0%
ROA
-163.2%
ROIC
-224.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $13.4M | 60.5% | $-44.0M | $-42.9M | $— | — |
| Q2 null | $22.3M | 68.3% | $-10.3M | $-20.0M | $— | — |
| Q1 null | $26.6M | 68.5% | $-13.1M | $-10.4M | $— | — |
| Q4 null | $46.0M | 78.3% | $-563.0K | $-615.0K | $— | — |
| FY null | $192.4M | 79.5% | $6.0M | $3.0M | $— | — |
| Q3 null | $50.0M | 79.6% | $3.8M | $2.4M | $— | — |
| Q2 null | $49.9M | 80.0% | $2.2M | $1.2M | $— | — |
| Q1 null | $46.5M | 80.0% | $525.0K | $10.0K | $— | — |
| Q4 null | $47.3M | 78.3% | $2.3M | $1.2M | $— | — |
| FY null | $184.3M | 79.2% | $10.8M | $9.7M | $— | — |
| Q3 2023 | $49.9M | 80.9% | $5.5M | $3.6M | $0.10 | — |
| Q2 2023 | $45.0M | 79.4% | $2.7M | $3.4M | $0.09 | — |